These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32876642)

  • 1. Watch and wait for rectal cancer: assessing the cost effectiveness in Latin America.
    Luna-Abanto J
    Rev Gastroenterol Peru; 2020; 40(2):204-205. PubMed ID: 32876642
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
    Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
    Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoiding Radical Surgery in Elderly Patients With Rectal Cancer Is Cost-Effective.
    Rao C; Sun Myint A; Athanasiou T; Faiz O; Martin AP; Collins B; Smith FM
    Dis Colon Rectum; 2017 Jan; 60(1):30-42. PubMed ID: 27926555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cost-Effectiveness Analysis of Contact X-ray Brachytherapy for the Treatment of Patients with Rectal Cancer Following a Partial Response to Chemoradiotherapy.
    Rao C; Smith FM; Martin AP; Dhadda AS; Stewart A; Gollins S; Collins B; Athanasiou T; Sun Myint A
    Clin Oncol (R Coll Radiol); 2018 Mar; 30(3):166-177. PubMed ID: 29248311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact X-ray Brachytherapy as an Adjunct to a Watch and Wait Approach is an Affordable Alternative to Standard Surgical Management of Rectal Cancer for Patients with a Partial Clinical Response to Chemoradiotherapy.
    Rao C; Stewart A; Martin AP; Collins B; Pritchard DM; Athanasiou T; Sun Myint A
    Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):625-633. PubMed ID: 30196845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
    Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness and Quality-Adjusted Survival of Watch and Wait After Complete Response to Chemoradiotherapy for Rectal Cancer.
    Miller JA; Wang H; Chang DT; Pollom EL
    J Natl Cancer Inst; 2020 Aug; 112(8):792-801. PubMed ID: 31930400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cost-effectiveness of Watch and Wait for Rectal Cancer.
    Bibi S; Edilbe MW; Rao C
    Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):132-137. PubMed ID: 36266161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Analysis of Total Neoadjuvant Therapy Followed by Radical Resection Versus Conventional Therapy for Locally Advanced Rectal Cancer.
    Wright ME; Beaty JS; Thorson AG; Rojas R; Ternent CA
    Dis Colon Rectum; 2019 May; 62(5):568-578. PubMed ID: 30964794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
    Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
    Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is "watch-and-wait" after chemoradiotherapy safe in patients with rectal cancer?
    Smith FM; Cresswell K; Myint AS; Renehan AG
    BMJ; 2018 Nov; 363():k4472. PubMed ID: 30425053
    [No Abstract]   [Full Text] [Related]  

  • 12. Definitive Chemoradiotherapy ("Watch-and-Wait" Approach).
    Goodman KA
    Semin Radiat Oncol; 2016 Jul; 26(3):205-10. PubMed ID: 27238472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or "watch and wait".
    Lai CL; Lai MJ; Wu CC; Jao SW; Hsiao CW
    Int J Colorectal Dis; 2016 Feb; 31(2):413-9. PubMed ID: 26607907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Watch and wait" approach in rectal cancer patients following complete clinical response to neoadjuvant chemoradiotherapy does not compromise oncologic outcomes.
    Neşşar G; Demirbağ AE; Mısırlıoğlu HC; Sezer S
    Turk J Gastroenterol; 2019 Nov; 30(11):951-956. PubMed ID: 31767549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Watch and wait for rectal cancer: where are we really at?
    Smith FM; Winter D
    Colorectal Dis; 2014 May; 16(5):332-4. PubMed ID: 24725661
    [No Abstract]   [Full Text] [Related]  

  • 16. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
    Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Watch and Wait: What is in the Box of this Organ-Preservation Strategy?
    Perez RO
    Ann Surg Oncol; 2022 Mar; 29(3):1516-1517. PubMed ID: 34997413
    [No Abstract]   [Full Text] [Related]  

  • 18. Watch-and-Wait is an Option in Rectal Cancer Patients: From Controversy to Common Clinical Practice.
    Grotenhuis BA; Beets GL
    Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):124-129. PubMed ID: 36481218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.
    Fernandez LM; São Julião GP; Figueiredo NL; Beets GL; van der Valk MJM; Bahadoer RR; Hilling DE; Meershoek-Klein Kranenbarg E; Roodvoets AGH; Renehan AG; van de Velde CJH; Habr-Gama A; Perez RO;
    Lancet Oncol; 2021 Jan; 22(1):43-50. PubMed ID: 33316218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
    Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.